title: Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?
authors.forename: L
authors.initials: L
authors.lastname: Sigalotti
authors.forename: E
authors.initials: E
authors.lastname: Fratta
authors.forename: G
authors.initials: G
authors.lastname: Parisi
authors.forename: S
authors.initials: S
authors.lastname: Coral
authors.forename: M
authors.initials: M
authors.lastname: Maio
mesh_terms: D019943:Amino Acid Substitution / Q000235:genetics; D018450:Disease Progression; D018698:Glutamic Acid / Q000235:genetics; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D020125:Mutation, Missense / Q000502:physiology; D009362:Neoplasm Metastasis; D011379:Prognosis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics* / Q000378:metabolism; D012641:Selection, Genetic / Q000502:physiology*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D016896:Treatment Outcome; D014633:Valine / Q000235:genetics
chemical_list: D018698:Glutamic Acid; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D014633:Valine